Kelvin joined DeepCure in 2022 as Director of Drug Metabolism and Pharmacokinetics (DMPK). He has broad experience and expertise in analytical chemistry, DMPK, and CMC (Chemistry, Manufacturing, and Control) areas. Since 1984, Kelvin’s career has spanned large multinational (Syntex/Roche, Wyeth/Pfizer, Aventis/Sanofi, Alcon/Novartis), small biotech (Assembly Biosciences), and non-profit (CHDI) organizations. He contributed to the discovery or development of multiple molecular entities to successful NDAs. Kelvin received his Ph.D. in Chemistry from the University of Illinois and post-doctoral training at Cornell University.